Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs. … its artificial intelligence (AI …
https://finance.yahoo.com/news/kaleido-biosciences-announces-pricing-public-030300444.html

